Photocatalysis technology company Acceled LLC has introduced the cLight, a cellular catalyst device suited for drug discovery and university research. According to the Pennsburg, Pennsylvania–based company, the cLight can facilitate genetic research, drug development, proteomics and diagnostics development by speeding chemical reactions with photoredox catalysis.
David MacMillan, a Nobel Prize in Chemistry winner and Princeton professor, was involved in the design of the cLight instrument. MacMillan’s lab is using the technology in cell research to further drug discovery.
The cLight supports statistical comparison between protein interaction networks.
Operating at 450 nm, the device enables researchers to streamline workflows by illuminating multiple plates simultaneously and uniformly (greater than 95% across the working area) for fast, repeatable results. cLight also features programmable reaction times and temperature limits. Cooling capabilities help avoid temperatures that exceed the level compatible with the biological sample, offering more flexibility when conducting biological experiments involving fragile samples.
The benchtop cLight has a compact footprint of 18″ L x 11.375″ W x 6.7″ H. Its active LED area measures 12.9″ x 8.6.” The device’s touchscreen measures 4.3″ on the diagonal.
The LED platform supports a 3.5” diameter six-plex arrangement to provide biochemists with experiment repeatability and simultaneous experiments.
The cLight offers greater than 95% uniformity across the working area of illumination.
Prominent universities and drug developers are using the cLight.
The cLight supports single or multi-plate catalysis experimentation while offering both uniform LED illumination and cooling.
The company offers academic pricing for its instruments.
Filed Under: Drug Discovery, Drug Discovery and Development